셀리드
2,125KRWMarket close of 10/27 (Tue)
Up +1.92%+40KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)2,040KRWDown -4.00%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 2,085
- High
- 2,145
- Low
- 2,050
- Day range
- Day range low 2,050 high 2,145, open 2,085, close 2,125, previous close 2,085
- Volume
- 10×10K shares
- 206.93 million KRW 0.07× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
36%36% of the way up from the lowest close in 1 year (252 sessions) · -48.3% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move+1.92%usual range
- Trading value0.1×usual range
See the full check report
Filings in the last 2 years · 0
Material events are checked for the top 400 stocks only — this stock shows periodic reports only.
- 2024-05-16Quarterly report (2024.03)
Same sector · 바이오 R&D
Down -0.67%· 26 of 64 stocks up, preferred shares excluded · trading value 190.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.6% | Flat 0.00% | 51.8B KRW |
| 올릭스 | Close over the last 20 sessions -11.8% | Down -5.72% | 24.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -8.3% | Up +0.37% | 14.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -20.9% | Down -1.54% | 12.1B KRW |
| 페니트리움바이오 | Close over the last 20 sessions -4.2% | Up +14.41% | 9.8B KRW |
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.